Coherus Biosciences Inc

Loqtorzi

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Coherus Biosciences Inc

Loqtorzi HCPCS:

J3263

HCPCS Code Descriptor:

Inj, toripalimab-tpzi, 1 mg

Category:

J Code

Loqtorzi NDCs:

70114-0340-01

Primary Type:

Antibiotic

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Loqtorzi CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Loqtorzi:

Loqtorzi is a medication manufactured by Coherus Biosciences Inc and aligned to the J Code: J3263. Loqtorzi is administered via the Intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J3263 Added Date:

1-Jul-24

J3263 Effective Date:

1-Jul-24

J3263 Termination Date:

HCPCS Active

Our team did not identify patient assistance information for Loqtorzi
Patient assistance information for Loqtorzi can be found through Loqtorzi Solutions at the following URL: https://loqtorzihcp.com/loqtorzi-solutions/
Loqtorzi prescribing information can be found at the link below:
Information regarding Loqtorzi’s side effect information can be found at Medline Plus.